Cyclic dinucleotides containing benzimidazole, method for the production of same, and use of same to activate stimulator of interferon genes (sting)-dependent signaling pathways
US11001605B2 · kind B2 · utility
6Cited by
1References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 2, 2017 |
| Grant date | May 11, 2021 |
| Priority date | — |
| Expiry date | Oct 2, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12P19/40
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cyclic dinucleotides are described, which in contrast to their natural congeners carry lipophilic nucleobases and have higher membrane permeability and increased biological activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.